Efficacy and Safety of Intratumoral Injection of Recombinant Human Adenovirus Type 5 Combined With Tislelizumab and Lenvatinib in the Treatment of Advanced Hepatocellular Carcinoma
Clinical trial NCT06253598 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06253598
- Sponsor
- The First Affiliated Hospital of Bengbu Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-30
- Primary completion
- 2025-12-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.